| PERIOD ENDING | 30-Nov-08 | 30-Nov-07 | 30-Nov-06 | | Total Revenue | 14,646,000 | 13,033,000 | 11,839,000 | | Cost of Revenue | 9,039,000 | 7,628,000 | 6,791,000 | | | Gross Profit | 5,607,000 | 5,405,000 | 5,048,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 1,629,000 | 1,579,000 | 1,447,000 | | Non Recurring |
-
|
-
|
-
| | Others | 1,249,000 | 1,101,000 | 988,000 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,729,000 | 2,725,000 | 2,613,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 62,000 | 66,000 | 17,000 | | Earnings Before Interest And Taxes | 2,791,000 | 2,791,000 | 2,630,000 | | Interest Expense | 414,000 | 367,000 | 312,000 | | Income Before Tax | 2,377,000 | 2,424,000 | 2,318,000 | | Income Tax Expense | 47,000 | 16,000 | 39,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,330,000 | 2,408,000 | 2,279,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,330,000 | 2,408,000 | 2,279,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,330,000 | $2,408,000 | $2,279,000 |
|
0.31% Nasdaq 
0.05%
Income Statement
